Caprihans India Limited (BOM:509486)

Market Cap	972.79M -53.7%
Revenue (ttm)	7.07B -5.0%
Net Income	-516.70M
EPS	-35.49
Shares Out	14.62M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,164
Average Volume	3,357
Open	69.70
Previous Close	66.52
Day's Range	65.00 - 69.75
52-Week Range	65.38 - 167.70
Beta	0.25
RSI	21.47
Earnings Date	Feb 10, 2026

About Caprihans India

Caprihans India Limited engages in the pharmaceutical packaging business in India and internationally. The company also manufactures and sells rigid and flexible polyvinyl chloride (PVC) films, polyvinylidene chloride (PVDC) coated films, plastic extruded products, alu alu foils, and other allied products. In addition, it provides thermoforming blister films under the Duplex, Triplex, Ultra, Ultra Tx, Armour, Aclar, Excel, Exxtra, Optra, BAPP, Zymax, Zymax Tx, and Zymax PDP names; coldforming blister foils under the Venus, Venus PR, Venus SBC, ...

• Industry: Miscellaneous Plastics Products
• Founded: 1946
• Employees: 540
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 509486

Financial Performance

In fiscal year 2025, Caprihans India's revenue was 7.40 billion, an increase of 6.36% compared to the previous year's 6.95 billion. Losses were -621.80 million, 20.5% more than in 2024.